NCT00550784View on ClinicalTrials.gov

Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

cisplatin

DRUG

cyclophosphamide

DRUG

melphalan

DRUG

paclitaxel

DRUG

topotecan hydrochloride

GENETIC

TdT-mediated dUTP nick end labeling assay

GENETIC

gene expression analysis

OTHER

immunohistochemistry staining method

OTHER

pharmacological study

PROCEDURE

peripheral blood stem cell transplantation

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00550784 - Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | Biotech Hunter | Biotech Hunter